by Riley Nolan | Aug 22, 2022 | Featured, Thinking Out Loud -Blog
After almost three year of virtual meetings, EpiVax is back on the road in earnest this fall! We are so excited to reconnect in person with our clients, partners and friends around the globe. And this fall we have an ambitious travel schedule! Check out the list...
by Riley Nolan | Aug 1, 2022 | Featured, Thinking Out Loud -Blog
Defining Fearless Science If you’ve been reading “Thinking out Loud” since I started writing this blog, you know that we espouse the concept of Fearless Science. Meaning, we report what we see, even if it doesn’t fit the dogma. Take COVID...
by Riley Nolan | Nov 30, 2021 | Featured, News
PROVIDENCE, RI, November 30, 2021 /PRNewswire/ — Today EpiVax, Inc. (“EpiVax”) confirmed that the company’s EPV-CoV-19 vaccine epitope sequences are 98.2% conserved in the new Omicron SARS-CoV-2 variant. EpiVax and EpiVax Therapeutics, Inc....
by Riley Nolan | Nov 30, 2021 | Featured, Thinking Out Loud -Blog
Omicron, Oh My! Want to know if Omicron, the new COVID-19 variant, becoming ‘more stealth’? Watch our LinkedIn for an update on whether we expect to see the Variant of Concern escaping vaccine-induced immune response. I’ll be posting that on Tuesday Nov...
by Riley Nolan | Nov 17, 2021 | Featured, News
PROVIDENCE, RI, November 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication of three papers focusing on malaria vaccine efficacy, part of a collaboration with Leidos, the University of Georgia Center for Vaccines and Immunology, the University...